expert roundtables

Improving Response Durability in High-Risk MDS and AML
Uncategorized

Improving Response Durability in High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Integrating Genomics Into the Classification and Management of MDS
Uncategorized

Integrating Genomics Into the Classification and Management of MDS

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML
Uncategorized

Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Metastatic Neuroendocrine Tumors With Carcinoid Syndrome: Individualized Care
Oncology

Metastatic Neuroendocrine Tumors With Carcinoid Syndrome: Individualized Care

expert roundtables
By Jonathan R. Strosberg, MD; Lowell B. Anthony, MD, FACP; Timothy J. Hobday, MD
Diagnosis of Carcinoid Syndrome and Neuroendocrine Tumors
Oncology

Diagnosis of Carcinoid Syndrome and Neuroendocrine Tumors

expert roundtables
By Jonathan R. Strosberg, MD; Lowell B. Anthony, MD, FACP; Timothy J. Hobday, MD
Load More